Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Research Reports

Multiplex Biomarker Imaging Market Growing At Steady CAGR Of 12% To 2029 With Leading Players In Market

Published On :

A new report published by FMI titled “Multiplex Biomarker Imaging Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027) studies the performance of the global multiplex biomarker imaging market over a ten year assessment period from 2017 to 2027. The report presents the value forecast of the global multiplex biomarker imaging market and provides key insights into the factors driving market growth as well as the factors restricting market growth. The estimates point to a revenue growth from about US$ 270 Mn in 2017 to nearly US$ 843 Mn by 2027 end, resulting in a CAGR of 12% over the forecast period.

A sample of this report is available upon request@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3526

Global Multiplex Biomarker Imaging Market: Segmentation and Forecast

The global multiplex biomarker imaging market is segmented on the basis of component type, imaging technique, application and end-user.

The instrument segment is estimated to be valued at US$ 200.6 Mn in the year 2017 and is poised to reach a value of US$ 620.4 Mn at the end of the year 2027 and exhibit a CAGR of 12% during the period of assessment.

The software segment is estimated to be valued at US$ 41.2 Mn in the year 2017 and is slated to reach a value of US$ 133.2 Mn at the end of the year 2027 and exhibit a CAGR of 12.5% during the period of assessment.

The IHC Assay segment is estimated to be valued at US$ 177.9 Mn in the year 2017 and is slated to reach a value of US$ 557.4 Mn at the end of the year 2027 and exhibit a CAGR of 12.1% during the period of assessment.

The FISH Assay segment is estimated to be valued at US$ 59.4 Mn in the year 2017 and is poised to reach a value of US$ 179.4 Mn at the end of the year 2027 and exhibit a CAGR of 11.7% during the period of assessment.

The research segment is estimated to be valued at US$ 238.6 Mn in the year 2017 and is poised to reach a value of US$ 740.5 Mn at the end of the year 2027 and exhibit a CAGR of 12% during the period of assessment.

The translational laboratories segment is estimated to be valued at US$ 4 Mn in the year 2017 and is slated to touch a value of US$ 418.2 Mn at the end of the year 2027 and exhibit a CAGR of 12.8% during the period of assessment.

Global Multiplex Biomarker Imaging Market: Regional Forecast

Future Market Insights tracks the performance of the global multiplex biomarker imaging market across the key geographies of North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan, and Middle East and Africa. As per the forecast of Future Market Insights, the North America multiplex biomarker imaging market is estimated to be valued at US$ 152.4 Mn in the year 2017 and is slated to touch a value of US$ 501.4 Mn at the end of the year 2027 and exhibit a CAGR of 12.6% during the assessment period. The Western Europe multiplex biomarker imaging market is estimated to be valued at US$ 64.7 Mn in the year 2017 and is poised to touch a value of US$ 208.6 Mn at the end of the year 2027 and exhibit a CAGR of 12.4% during the period of assessment.

Global Multiplex Biomarker Imaging Market: Vendor Insights

The report has included some of the key players operating in the global multiplex biomarker imaging market such as Perkin Elmer, Inc., Bio-rad Laboratories Inc., Thermo Fisher Scientific, Inc., Abcam plc., Merck KGaA, Illumina Inc., Leica Biosystems Nussloch GmbH, Ventana Medical Systems, Inc., Aushon BioSystems Ltd., MicroConstants, Inc. and ToposNomos Ltd. Leading manufacturer of Multiplex Biomarker Imaging are focusing on collaborations with laboratories and biopharmaceutical companies in order to expand sales presence. Other companies are focusing on targeting technologically advanced emerging economies such as Asia Pacific region with availability of sufficient capital base and skilled labour.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com

The post Multiplex Biomarker Imaging Market Growing At Steady CAGR Of 12% To 2029 With Leading Players In Market appeared first on Industry News Analsis.

Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts